CFTC Announces Four Whistleblower Awards Totaling $4.5 Million to Seven Recipients

The CFTC announced four orders granting whistleblower awards totaling approximately $4.5 million to seven whistleblowers, marking the most awards issued on a single day in the program's history. The awards recognize whistleblowers who provided information leading to successful enforcement actions, including victims of fraud, market participants, and employees who reported violations internally after 120 days without remedial action.

CFTC Awards Approximately $700,000 to Whistleblower

The CFTC announced a whistleblower award of approximately $700,000 to an individual whose information prompted the agency to open an investigation and described misconduct that appeared in the enforcement order. The whistleblower provided substantial assistance that helped conserve Commission resources, though the award was reduced due to unreasonable delay in reporting and whistleblower culpability. Since 2014, the CFTC has granted awards totaling approximately $390 million associated with enforcement actions resulting in over $3.2 billion in monetary sanctions.

CFTC Awards Over $4 Million to Insider Whistleblower

The Commodity Futures Trading Commission announced an award of over $4 million to an insider whistleblower who provided information that enabled the Division of Enforcement to open an investigation into ongoing misconduct involving complex products and transactions. The whistleblower reported failures to comply with CFTC rules protecting against fraudulent, deceptive, and manipulative practices, and cooperated throughout the investigation.

Composition Comprising Lactic Acid Bacteria Derived from Green Tea for Improving Liver Function

USPTO granted patent US12594310B2 to AMOREPACIFIC CORPORATION on April 7, 2026, covering a method for improving hepatic function using a composition derived from green tea-derived Lactiplantibacillus plantarum strain. The patent includes 6 claims and covers the strain, culture, lysate, and extracts thereof.

Method for treating liver cirrhosis using mesenchymal stem cell composition

The USPTO granted patent US12594304B2 to GWO XI STEM CELL APPLIED TECHNOLOGY CO., LTD. for a method of treating liver cirrhosis using a composition comprising mesenchymal stem cells, extracellular vesicles produced by mesenchymal stem cells, and growth factors. The patent contains 15 claims and is classified under CPC codes A61K 35/28, A61K 9/0019, and A61P 1/16.

Use of ENTPD3 for identification, isolation, and enhancing mature stem cell derived insulin-producing cells

The USPTO granted patent US12594306B2 to the Regents of the University of Colorado on April 7, 2026. The patent covers methods and compositions for identifying, sorting, and separating stem cell-derived pancreatic beta cells using the cell surface protein ENTPD3 (CD39L3) for diabetes treatment applications. The patent includes 13 claims and has a filing date of March 25, 2022.

Methods of preparing a postbiotic composition

USPTO granted patent US12594308B2 to Science Power SRL covering methods of preparing postbiotic compositions through multiple separate microbial fermentations. The patent, based on Application No. 18909568 filed October 8, 2024, includes 15 claims and lists Federica Nigro as the inventor. The composition may be produced via parallel or sequential fermentation steps.

Methods of administering safe colon cleansing compositions

USPTO granted patent US12594298B2 to Azurity Pharmaceuticals covering methods of administering colon cleansing compositions. The patent protects formulations comprising salt mixtures that induce purgation without requiring adjunct laxatives like bisacodyl, offering improved tolerability and patient compliance. The patent names Edmund V. Dennett, Mark Cleveland, Russell W. Pelham, and Matthew Walker as inventors, with 3 claims allowed.

Philadelphia Man Charged as Repeat Offender with CSAM Distribution and Invasion of Privacy

Pennsylvania Attorney General Dave Sunday announced criminal charges against Jason Sheasley, 40, of Philadelphia, for possession and distribution of child sexual abuse material and invasion of privacy. Sheasley, a repeat offender with a 2016 New Jersey conviction, was arraigned on nine felonies and three misdemeanors with $500,000 bail set. The investigation began in January when agents discovered Sheasley sharing CSAM videos online and found evidence of unauthorized video recording of a woman.

Revenue Procedure 2026-14 - Qualified Opportunity Zone Nominations Procedure

The IRS issued Revenue Procedure 2026-14 to provide guidance to State CEOs on the procedural requirements for nominating population census tracts as Qualified Opportunity Zones (QOZs) for designation effective January 1, 2027. The guidance implements amendments made by Section 70421 of the One, Big, Beautiful Bill Act (OBBBA) to IRC Sections 1400Z-1 and 1400Z-2. Nominating authorities must follow the prescribed process to designate low-income community census tracts as QOZs.